Psychiatric disorders as debut of acute intermittent porphyria in a patient with no family history
Keywords:
PORPHYRIAS, HEME, PORPHOBILINOGEN.Abstract
Introduction: acute porphyrias comprise a group of genetic disorders in the synthesis of the heme group, which can compromise life and whose clinical manifestations simulate other diseases such as: acute abdomen, peripheral neuropathy, primary psychiatric disorders, among others.
Case presentation: the delay in diagnosis, which is confirmed by demonstrating elevated levels of total porphyrins in blood and urine, delays the initiation of specific treatment, increasing morbimortality. We report a patient whose clinical manifestations led to several erroneous diagnoses, depriving her of adequate and timely treatment.
Conclusions: the clinical, diagnostic and therapeutic orientation are analyzed. Acute intermittent porphyria is rare but serious, and should be considered in young women with acute abdominal pain not attributable to other causes.
Downloads
References
1. Fuller SJ, Wiley SJ. Heme biosynthesis and its disorders: porphyrias and sideroblastic anemias. En: Hematology: Basic Principles and Practice. 7a.ed. [Internet]; 2019. Canada: Elsevier S.A [citado 09/09/2022]. Disponible en: https://www.sciencedirect.com/book/9780323357623/hematology?via=ihub=#book-description
2. Mejía JJ, Jaramillo G, Gómez LF, Jaramillo MA, Caballero D. Porfirias agudas: manifestaciones inespecíficas y manejo terapéutico específico. Repert Med Cir[Internet]. 2020 [citado 09/09/2022]; 29(1): 19-31. Disponible en: https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/886
3. Phillips JD, Anderson KE. The porphyrias. En: Williams Hematology 9a. ed [Internet]; 2017. Mc Graw-Hill companies [citado 09/09/2022]. Disponible en: https://accessmedicine.mhmedical.com/book.aspx?bookid=1581#94301149
4. Rodríguez R, Ricote M, Villarejo R, Iniesta R, Sánchez D, Oscullo V. Porfiria aguda intermitente, a propósito de un caso. Semergen[Internet]. 2017 [citado 09/09/2022]; 43(Espec Congr 7): 24. Disponible en: https://www.elsevier.es/es-revista-medicina-familia-semergen-40-congresos-1as-jornadas-nacionales-digestivo-semergen-62-sesion-casos-clinicos-posteres-3873
5. Jaramillo DA, Zapata A. Avances en el diagnóstico y tratamiento de la porfiria intermitente aguda. Med Int Méx[Internet]. 2017 [citada: 09/09/2022]; 33(5): 655-667. Disponible en: https://doi.org/10.24245/mim.v33i5.1405
6. García JM. Importancia de los factores desencadenantes y fármacos seguros en la porfiria aguda intermitente. Caso clínico. Revista Electrónica de Portales Médicos.com[Internet]. 2021 [citado 09/09/2022]. Disponible en:
7. Montoya M, Barranco L A, Herrera F. Porfiria aguda. Dilema diagnóstico y manifestaciones neuroendocrinas. Acta Med Colomb[Internet]. 2017 [citado 09/09/2022]; 42(2): 140-143. Disponible en: https://www.redalyc.org/articulo.oa?id=163152072009
8. Bustos J, Vargas L, Quintero R. Porfiria intermitente aguda: reporte de caso. Biomédica[Internet]. 2020 [citado 09/09/2022]; 40(1): 14-19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357387/
9. Erazo A, Erazo M, Zamora T . Porfiria intermitente aguda como desencadenante de síndrome de Guillain-Barre. Rev. Fac. Med[Internet]. 2019 [citado 09/09/2022]; 67(2): 349-55. Disponible en: http://www.redalyc.org/articulo.oa?id=576364238023
10. Tinoco J, Eloy A, Regufe R, Rosinha D, Taleco T, Duarte JS. Uso de sugammadex en la porfiria aguda intermitente. Rev mex anestesiol[Internet]. 2021 [citado 09/09/2022]; 44(3): 229-232. Disponible en: https://www.scielo.org.mx/scielo.php?pid=S0484-79032021000300229&script=sci_abstract&tlng=es
11. Shiqian H, Ruiting L, Yin Y. Severe neuropathic attack in a woman with acute intermittent porphyria: a case report. J Int Med Res[Internet]. 2021 [citado 09/09/2022]; 49(1). Disponible en : https://pubmed.ncbi.nlm.nih.gov/33430675/
12. Neeleman RA, Wagenmakers M, Koole-Lesuis RH, Mijnhout GS, Wilson J, Friesema E, et al. Medical and financial burden of acute intermittent porphyria. JIMD[Internet]. 2018 [citado 09/09/2022]; 41(5): 809–17. Disponible en: https://doi.org/10.1007/s10545-018-0178-z
13. Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute Intermittent Porphyria: Current Perspectives And Case Presentation. Ther Clin Risk Manag[Internet]. 2019 [citado 09/09/2022]; 15: 1443-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31908464/
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
